vimarsana.com

During the last session, Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD)’s traded shares were 2.18 million, with the beta value of the company hitting 1.16. At the end of the trading day, the stock’s price was $0.30, reflecting an intraday loss of -3.29% or -$0.01. The 52-week high for the GLM

Related Keywords

,Nasdaq ,Index Fund ,Morgan Stanley ,Delaware Group Equity Fds Healthcare Fund ,Galmed Pharmaceuticals Ltd ,Galmed Pharmaceuticals ,Stockwire News ,Wealth Building Report ,Wall Street ,Mutual Funds ,Delaware Group Equity Fds ,Delaware Healthcare Fund ,Rlmd ,Lmd Stock ,Nasdaq Glmd ,

© 2024 Vimarsana

vimarsana.com © 2020. All Rights Reserved.